Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
ID | DOID:5503 |
Name | spinal cord ependymoma |
Definition | A high grade ependymoma that has_material_basis_in cells linking the spinal cord central canal. |
Source | DiseaseOntology.org |
Alt Ids | |
Path | disease disease of cellular proliferation cancer cell type cancer high grade glioma high grade ependymoma spinal cord ependymoma |
Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT01295944 | Phase II | Bevacizumab + Carboplatin | Carboplatin and Bevacizumab for Recurrent Ependymoma | Completed | USA | 0 |
NCT02458339 | Phase I | Methotrexate | Methotrexate Infusion Into Fourth Ventricle in Children With Recurrent Malignant Fourth Ventricular Brain Tumors | Completed | USA | 0 |
NCT03727841 | Phase II | Marizomib | Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma | Terminated | USA | 0 |
NCT04958486 | Phase I | Azacitidine + Trastuzumab | Combination Intraventricular Chemotherapy Pilot Study: 5-Azacytidine (5-AZA) and Trastuzumab Infusions Into the Fourth Ventricle or Resection Cavity in Children and Adults With Recurrent or Residual Posterior Fossa Ependymoma | Recruiting | USA | 0 |